Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the anti-tumor effect of sirolimus-based
immunosuppressive regimen in patients following living donor liver transplantation for
hepatocellular carcinoma exceeding Milan criteria with respect to recurrence-free survival.